Kaikai Yi

2.1k total citations
34 papers, 1.6k citations indexed

About

Kaikai Yi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kaikai Yi has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Kaikai Yi's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Extracellular vesicles in disease (6 papers). Kaikai Yi is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Extracellular vesicles in disease (6 papers). Kaikai Yi collaborates with scholars based in China, United States and Germany. Kaikai Yi's co-authors include Chunsheng Kang, Qixue Wang, Yanli Tan, Yunfei Wang, Junhu Zhou, Chao Yang, Chuan Fang, Qi Zhan, Xubo Yuan and Yansheng Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Kaikai Yi

31 papers receiving 1.6k citations

Peers

Kaikai Yi

IMMUN

GENET

Jong Bae Park South Korea

Fatih Kocabaş Türkiye

Paulina Kucharzewska Poland

Shaojun Zhu China

Shenqi Zhang China

Xiao Gao China

Fotini M. Kouri United States

Zhendong Shi China

Okay Saydam United States

Patrizia Perri Italy

Jong Bae Park South Korea

Kaikai Yi

731 ×0.6

426 ×0.7

179 ×0.9

137 ×0.8

IMMUN

151 ×1.0

GENET

Citations per year, relative to Kaikai Yi Kaikai Yi (= 1×) peers Jong Bae Park

Countries citing papers authored by Kaikai Yi

Since Specialization

Citations

This map shows the geographic impact of Kaikai Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaikai Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaikai Yi more than expected).

Fields of papers citing papers by Kaikai Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaikai Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaikai Yi. The network helps show where Kaikai Yi may publish in the future.

Co-authorship network of co-authors of Kaikai Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Kaikai Yi. A scholar is included among the top collaborators of Kaikai Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaikai Yi. Kaikai Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Xiaojing, Nan Wang, Huihui Ren, et al.. (2025). Affinity Modifications of Porous Microscaffolds Impact Bone Regeneration by Modulating the Delivery Kinetics of Small Extracellular Vesicles. ACS Nano. 19(18). 17813–17823. 3 indexed citations

Hong, Biao, Shixue Yang, Xing Cui, et al.. (2025). Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma. Acta Pharmaceutica Sinica B. 15(7). 3632–3645.

Zhan, Qi, Kaikai Yi, Shixue Yang, et al.. (2025). LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastoma. Theranostics. 16(5). 2249–2268.

Zhang, Zhen, Qiang Yin, Peng Li, et al.. (2025). Cyst fluid ctDNA as a biomarker for genetic profiling and treatment monitoring in cystic brain metastases. British Journal of Cancer. 133(3). 325–336.

Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations

Li, Lijie, Qi Zhan, Kaikai Yi, et al.. (2022). Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy. Journal of Materials Chemistry B. 10(11). 1833–1842. 8 indexed citations

Xu, Can, Jixing Zhao, Jia L. Song, et al.. (2022). lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy. Frontiers in Oncology. 12. 888922–888922. 13 indexed citations

Yang, Shixue, Jixing Zhao, Xiaoteng Cui, et al.. (2022). TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma. Theranostics. 12(16). 7032–7050. 36 indexed citations

Yi, Kaikai, Xiaoteng Cui, Xing Liu, et al.. (2022). PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma. Frontiers in Immunology. 12. 802795–802795. 26 indexed citations

10.

Wang, Yunfei, Kaikai Yi, Xing Liu, et al.. (2021). HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas. Frontiers in Immunology. 12. 785463–785463. 31 indexed citations

11.

Zheng, Yadan, Zhanzhan Zhang, Qi Liu, et al.. (2020). Multifunctional Nanomodulators Regulate Multiple Pathways To Enhance Antitumor Immunity. ACS Applied Bio Materials. 3(7). 4635–4642. 19 indexed citations

12.

Liu, Qi, Chun Wang, Yadan Zheng, et al.. (2020). Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy. Biomaterials. 258. 120275–120275. 102 indexed citations

13.

Cai, Ying, Eryan Yang, Xiuhua Yao, et al.. (2020). FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury. Redox Biology. 38. 101792–101792. 163 indexed citations

14.

Li, Sidi, Luyang Chen, Kai Huang, et al.. (2019). Tumor Microenvironment‐Tailored Weakly Cell‐Interacted Extracellular Delivery Platform Enables Precise Antibody Release and Function. Advanced Functional Materials. 29(43). 25 indexed citations

15.

Li, Yansheng, Yu Ren, Yunfei Wang, et al.. (2019). A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 9(16). 4608–4623. 84 indexed citations

16.

Zhao, Kai, Xiaoteng Cui, Qixue Wang, et al.. (2019). RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner. Cell Death and Disease. 10(12). 877–877. 52 indexed citations

17.

Li, Jiuyi, Kaikai Yi, Jing Feng, et al.. (2019). Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma. Proceedings of the National Academy of Sciences. 116(14). 6975–6984. 34 indexed citations

18.

Huang, Kai, Chuan Fang, Kaikai Yi, et al.. (2018). The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes. Theranostics. 8(6). 1540–1557. 104 indexed citations

19.

Yang, Chao, Yansheng Li, Qixue Wang, et al.. (2017). EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells. Cancer Letters. 403. 119–127. 17 indexed citations

20.

Huang, Kai, Chao Yang, Qixue Wang, et al.. (2016). The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells. Cancer Letters. 388. 269–280. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact